Mountain Hill Investment Partners Corp. Iovance Biotherapeutics, Inc. Transaction History
Mountain Hill Investment Partners Corp.
- $102 Billion
- Q1 2025
A detailed history of Mountain Hill Investment Partners Corp. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mountain Hill Investment Partners Corp. holds 1,100 shares of IOVA stock, worth $3,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,100Holding current value
$3,850% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
245MCall Options Held
2.53MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$96.4 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$85.5 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$77.4 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$74.3 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$42.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $552M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...